Depression. Depressive episode
Conditions
Interventions
Intervention 1: Fluovoxamine, Tablets, 25 mg per day, orally for 8 weeks. Intervention 2: Flouxetine, Capsules, 10mg per day, orally for 8 weeks.
Treatment - Drugs
Fluovoxamine, Tablets, 25 mg per day, orally for 8 weeks
Flouxetine, Capsules, 10mg per day, orally for 8 weeks
Sponsors
Kashan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
8 Years to 18 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: IQ more than 70 characterized by psychologist and psychiatrist via clinical interview, age 8-17 years, having major depression without psychotic features based on DSM-IV Exclusion criteria: severe disabling physical illness, other medical problems that counteract with drug use or other antidepressant drugs, Severe mental disorders such as psychotic, bipoular disorders, catatonia symptoms, substance abuse
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Depression severity. Timepoint: Baseline and 2, 4, 8 weeks after the intervention. Method of measurement: CDI and CGAS. | — |
Secondary
| Measure | Time frame |
|---|---|
| Body weight. Timepoint: Baseline and 2, 4, and 8 weeks after intervention. Method of measurement: Body weight in Kg.;Adverse effect. Timepoint: Baseline and 2, 4, and 8 weeks after intervention. Method of measurement: any drug adverse effect. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactZahra Sepehrmanesh.MD
Kashan University of Medical Sciences
Outcome results
None listed